XML 45 R34.htm IDEA: XBRL DOCUMENT
v3.25.4

NET LOSS PER SHARE (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Earnings Per Share [Abstract] |
Schedule of Reconciliations of the Numerators and Denominators Used to Compute Basic and Diluted Earnings (Loss) Per Share | The following table sets forth reconciliations of the numerators and denominators used to compute basic and diluted net loss per share (in thousands, except per share amounts):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 (As Restated) |  | 2024 |  | 2025 (As Restated) |  | 2024
Numerator: |  |  |  |  |  |  |
Net loss | $ | (144,027) |  |  | $ | (455,259) |  |  | $ | (504,575) |  |  | $ | (1,146,725) |
Change in fair value of Tranche 2 Warrants | (849) |  |  | 111,834 |  |  | 33,311 |  |  | 111,834 |
Basic and diluted net loss | $ | (144,876) |  |  | $ | (343,425) |  |  | $ | (471,264) |  |  | $ | (1,034,891) |
Denominator: |  |  |  |  |  |  |
Weighted average shares outstanding - basic and diluted | 318,562 |  |  | 292,486 |  |  | 317,363 |  |  | 253,058 |
Net loss per share - basic and diluted | $ | (0.45) |  |  | $ | (1.17) |  |  | $ | (1.48) |  |  | $ | (4.09) |
Schedule of Antidilutive Securities Excluded from Computation of Earnings (Loss) Per Share | Pote ntially dilutive securities include securities excluded from the calculation of diluted EPS because to do so would be anti-dilutive. Shares which may be issued from potentially dilutive securities are as follows (in thousands):
| Three and Nine Months Ended
| September 30, 2025 |  | September 30, 2024
Tranche 1 Warrants | 97,394 |  |  | 98,079 |
Convertible Notes | 69,611 |  |  | 41,825 |
RSUs, PSUs, and MSUs | 24,792 |  |  | 22,019 |
Stock options | 344 |  |  | 369 |
Total shares issuable from potentially dilutive securities | 192,141 |  |  | 162,292 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration